← FDA Drug Approvals (Drugs@FDA)

ATORVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-05-19

Drug application

FDA Application #

ANDA205519

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATORVASTATIN CALCIUM

Generic name

ATORVASTATIN CALCIUM

Active ingredients

ATORVASTATIN CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Cipla USA Inc.,

First approval

2016-05-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown